Literature DB >> 23008174

Huntington's disease: how intermediate are intermediate repeat lengths?

Ferdinando Squitieri1, Joseph Jankovic.   

Abstract

BACKGROUND: Huntington's disease (HD) is a devastating heredoneurodegenerative disorder associated with a wide variety of neurological and psychiatric symptoms caused by an expanded CAG repeat in the HTT gene. The expansion mutation in HTT is dominantly transmitted and codes for a protein named huntingtin (htt). HYPOTHESIS: One hypothesis, according to a multistep mechanism, is that the intergenerational transmission of the normal repeat size causes small, progressive CAG stretch elongations in the general population from one generation to another, until a critical pathological CAG repeat threshold is reached. Mutations may originate in the offspring from paternally transmitted CAG repeats, falling within an intermediate alleles (IA) range of 27 to 35 in repeat length.
CONCLUSIONS: There has been emerging evidence that some individuals with IAs might develop an HD phenotype. This presents a challenge for genetic counseling, because these individuals are often reassured that they are "disease free." However, there are many unanswered questions related to the role of IAs in the development of the HD phenotype and in the pathogenesis of HD.
Copyright © 2012 Movement Disorder Society.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23008174     DOI: 10.1002/mds.25172

Source DB:  PubMed          Journal:  Mov Disord        ISSN: 0885-3185            Impact factor:   10.338


  14 in total

1.  Increased irritability, anxiety, and immune reactivity in transgenic Huntington's disease monkeys.

Authors:  Jessica Raper; Steven Bosinger; Zachary Johnson; Gregory Tharp; Sean P Moran; Anthony W S Chan
Journal:  Brain Behav Immun       Date:  2016-07-07       Impact factor: 7.217

2.  Huntington's disease: lessons from prion disorders.

Authors:  Melanie Alpaugh; Francesca Cicchetti
Journal:  J Neurol       Date:  2021-02-24       Impact factor: 4.849

Review 3.  Huntington disease: natural history, biomarkers and prospects for therapeutics.

Authors:  Christopher A Ross; Elizabeth H Aylward; Edward J Wild; Douglas R Langbehn; Jeffrey D Long; John H Warner; Rachael I Scahill; Blair R Leavitt; Julie C Stout; Jane S Paulsen; Ralf Reilmann; Paul G Unschuld; Alice Wexler; Russell L Margolis; Sarah J Tabrizi
Journal:  Nat Rev Neurol       Date:  2014-03-11       Impact factor: 42.937

Review 4.  Prospects for neuroprotective therapies in prodromal Huntington's disease.

Authors:  Abhishek Chandra; Ashu Johri; M Flint Beal
Journal:  Mov Disord       Date:  2014-02-26       Impact factor: 10.338

5.  Altered lactate metabolism in Huntington's disease is dependent on GLUT3 expression.

Authors:  Macarena Solís-Maldonado; María Paz Miró; Aníbal I Acuña; Adriana Covarrubias-Pinto; Anitsi Loaiza; Gonzalo Mayorga; Felipe A Beltrán; Carlos Cepeda; Michael S Levine; Ilona I Concha; Luis Federico Bátiz; Mónica A Carrasco; Maite A Castro
Journal:  CNS Neurosci Ther       Date:  2018-04       Impact factor: 5.243

Review 6.  Trinucleotide expansion in disease: why is there a length threshold?

Authors:  Do-Yup Lee; Cynthia T McMurray
Journal:  Curr Opin Genet Dev       Date:  2014-10-01       Impact factor: 5.578

7.  Progressive cognitive deficit, motor impairment and striatal pathology in a transgenic Huntington disease monkey model from infancy to adulthood.

Authors:  Anthony W S Chan; Jie Jiang; Yiju Chen; Chunxia Li; Melinda S Prucha; Yijuan Hu; Tim Chi; Sean Moran; Tayeb Rahim; Shihua Li; Xiaojiang Li; Stuart M Zola; Claudia M Testa; Hui Mao; Rosa Villalba; Yoland Smith; Xiaodong Zhang; Jocelyne Bachevalier
Journal:  PLoS One       Date:  2015-05-12       Impact factor: 3.240

Review 8.  Targeting the proteostasis network in Huntington's disease.

Authors:  Tânia R Soares; Sara D Reis; Brígida R Pinho; Michael R Duchen; Jorge M A Oliveira
Journal:  Ageing Res Rev       Date:  2018-11-28       Impact factor: 10.895

9.  High frequency of intermediary alleles in the HTT gene in Northern Sweden - The Swedish Huntingtin Alleles and Phenotype (SHAPE) study.

Authors:  Jimmy Sundblom; Valter Niemelä; Maria Ghazarian; Ann-Sofi Strand; Ingvar A Bergdahl; Jan-Håkan Jansson; Stefan Söderberg; Eva-Lena Stattin
Journal:  Sci Rep       Date:  2020-06-17       Impact factor: 4.996

10.  Parkinsonism with a Hint of Huntington's from 29 CAG Repeats in HTT.

Authors:  Sipilä Jot
Journal:  Brain Sci       Date:  2019-09-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.